» Articles » PMID: 28124310

Subclinical Right Ventricular Dysfunction in Patients with Severe Aortic Stenosis: A Retrospective Case Series

Overview
Journal Cardiol Ther
Date 2017 Jan 27
PMID 28124310
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: There is scarce information about right ventricle (RV) function in patients with secondary pulmonary hypertension (PH) undergoing transcatheter aortic valve implantation (TAVI). We aim to identify possible RV abnormalities in patients referred for TAVI with severe aortic stenosis (sAS) and secondary PH.

Methods: Objective measures of RV function, as well as noninvasive estimates of pulmonary artery systolic pressures (PASP) were obtained from 30 sAS patients undergoing percutaneous valve intervention.

Results: Sixteen (53%) evaluated patients had some degree of PH. As expected, left ventricular mass index (281 ± 75 g/m) and left atrial volume index (89 ± 23 mL/m) values were significantly elevated. Even though RV end-systolic (8 ± 4 cm) and end-diastolic (17 ± 4 cm) areas were normal as well as RV fractional area change values (57 ± 16%); both longitudinal measures of RV systolic function such as tricuspid annular plane systolic excursion (1.9 ± 0.5 cm) and systolic velocity (10 ± 2 cm/s) were clearly reduced with just mild elevations in PASP (54 ± 7 mmHg).

Conclusions: Subclinical RV dysfunction is present in patients with sAS and secondary PH undergoing TAVI. Whether longitudinal measures of RV systolic function could predict clinical outcomes in these patients needs to be further explored.

Citing Articles

Aortic stenosis and right ventricular dysfunction.

Fulop P, Valocik G, Barbierik Vachalcova M, Zenuch P, Filipova L Int J Cardiovasc Imaging. 2023; 40(2):299-305.

PMID: 37950827 PMC: 10884046. DOI: 10.1007/s10554-023-02986-9.


Elevated systolic pulmonary artery pressure is a substantial predictor of increased mortality after transcatheter aortic valve replacement in males, not in females.

Boxhammer E, Dienhart C, Kletzer J, Ramsauer S, Kopp K, Prinz E Clin Res Cardiol. 2023; 113(1):138-155.

PMID: 37750991 PMC: 10808322. DOI: 10.1007/s00392-023-02307-z.


Isolated Subclinical Right Ventricle Systolic Dysfunction in Patients after Liver Transplantation.

Guler E, Omaygenc M, Naki D, Yazar A, Karaca I, Korkut E J Clin Med. 2023; 12(6).

PMID: 36983288 PMC: 10059715. DOI: 10.3390/jcm12062289.


CT measured pulmonary artery to ascending aorta ratio stratified by echocardiographically obtained systolic pulmonary artery pressure values for noninvasive detection of pulmonary hypertension in patients with severe aortic valve stenosis.

Boxhammer E, Kletzer J, Kellermair J, Scharinger B, Kaufmann R, Hammerer M Clin Res Cardiol. 2023; 112(10):1394-1416.

PMID: 36935421 PMC: 10562282. DOI: 10.1007/s00392-023-02182-8.


Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Systematic Review of Non-Invasive Ways of Risk Stratification, Especially in Patients Undergoing Transcatheter Aortic Valve Replacement.

Boxhammer E, Berezin A, Paar V, Bacher N, Topf A, Pavlov S J Pers Med. 2022; 12(4).

PMID: 35455719 PMC: 9026430. DOI: 10.3390/jpm12040603.


References
1.
Barbash I, Escarcega R, Minha S, Ben-Dor I, Torguson R, Goldstein S . Prevalence and impact of pulmonary hypertension on patients with aortic stenosis who underwent transcatheter aortic valve replacement. Am J Cardiol. 2015; 115(10):1435-42. DOI: 10.1016/j.amjcard.2015.02.022. View

2.
Pai R, Varadarajan P, Kapoor N, Bansal R . Aortic valve replacement improves survival in severe aortic stenosis associated with severe pulmonary hypertension. Ann Thorac Surg. 2007; 84(1):80-5. DOI: 10.1016/j.athoracsur.2007.02.094. View

3.
Lopez-Candales A, Rajagopalan N, Gulyasy B, Edelman K, Bazaz R . Comparative echocardiographic analysis of mitral and tricuspid annular motion: differences explained with proposed anatomic-structural correlates. Echocardiography. 2007; 24(4):353-9. DOI: 10.1111/j.1540-8175.2006.00408.x. View

4.
Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G . Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007; 28(2):230-68. DOI: 10.1093/eurheartj/ehl428. View

5.
Lindman B, Maniar H, Jaber W, Lerakis S, Mack M, Suri R . Effect of tricuspid regurgitation and the right heart on survival after transcatheter aortic valve replacement: insights from the Placement of Aortic Transcatheter Valves II inoperable cohort. Circ Cardiovasc Interv. 2015; 8(4). PMC: 4438083. DOI: 10.1161/CIRCINTERVENTIONS.114.002073. View